JP2025032196A5 - - Google Patents
Info
- Publication number
- JP2025032196A5 JP2025032196A5 JP2024211090A JP2024211090A JP2025032196A5 JP 2025032196 A5 JP2025032196 A5 JP 2025032196A5 JP 2024211090 A JP2024211090 A JP 2024211090A JP 2024211090 A JP2024211090 A JP 2024211090A JP 2025032196 A5 JP2025032196 A5 JP 2025032196A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- cycloalkyl
- membered
- haloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163167331P | 2021-03-29 | 2021-03-29 | |
| US63/167,331 | 2021-03-29 | ||
| JP2023560087A JP7705475B2 (ja) | 2021-03-29 | 2022-03-25 | Ｋｈｋ阻害剤 |
| PCT/US2022/021912 WO2022212194A1 (en) | 2021-03-29 | 2022-03-25 | Khk inhibitors |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560087A Division JP7705475B2 (ja) | 2021-03-29 | 2022-03-25 | Ｋｈｋ阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025032196A JP2025032196A (ja) | 2025-03-11 |
| JP2025032196A5 true JP2025032196A5 (cg-RX-API-DMAC10.html) | 2025-09-04 |
| JP7778900B2 JP7778900B2 (ja) | 2025-12-02 |
Family
ID=81388962
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560087A Active JP7705475B2 (ja) | 2021-03-29 | 2022-03-25 | Ｋｈｋ阻害剤 |
| JP2024211090A Active JP7778900B2 (ja) | 2021-03-29 | 2024-12-04 | Ｋｈｋ阻害剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560087A Active JP7705475B2 (ja) | 2021-03-29 | 2022-03-25 | Ｋｈｋ阻害剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12410160B2 (cg-RX-API-DMAC10.html) |
| EP (2) | EP4681774A3 (cg-RX-API-DMAC10.html) |
| JP (2) | JP7705475B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230158542A (cg-RX-API-DMAC10.html) |
| CN (1) | CN117120429A (cg-RX-API-DMAC10.html) |
| AR (1) | AR125238A1 (cg-RX-API-DMAC10.html) |
| AU (2) | AU2022252182B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3214961A1 (cg-RX-API-DMAC10.html) |
| ES (1) | ES3061522T3 (cg-RX-API-DMAC10.html) |
| PL (1) | PL4313967T3 (cg-RX-API-DMAC10.html) |
| TW (2) | TW202448875A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022212194A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024544794A (ja) * | 2021-12-24 | 2024-12-04 | エルジー・ケム・リミテッド | （ｓ）－２－（２－メチルアゼチジン－１－イル）ピリミジン誘導体およびそれを含む医薬組成物 |
| IL319915A (en) * | 2022-10-24 | 2025-05-01 | Yuhan Corp | Improved processes for the preparation of dimethyl-3,2-dihydro-1H-indene derivatives |
| WO2024125482A1 (zh) * | 2022-12-13 | 2024-06-20 | 华领医药技术（上海）有限公司 | 作为己酮糖激酶抑制剂的化合物、其用途以及包含其的组合物 |
| AU2025229421A1 (en) * | 2024-02-26 | 2026-08-13 | Mira Pharmaceuticals, Inc. | Synthetic cannabinoid analogs, pharmaceutical compositions and methods of treating anxiety and other disorders |
| WO2025250674A1 (en) * | 2024-05-30 | 2025-12-04 | Miralogx Llc | Synthetic cannabinoid analogs, pharmaceutical compositions and methods of treating neurological disorders and other conditions |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5041443A (en) * | 1989-02-21 | 1991-08-20 | Dainippon Pharmaceutical Co., Ltd. | Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof |
| US5137890A (en) | 1990-02-14 | 1992-08-11 | Ortho Pharmaceutical Corporation | 4-phenyl tetrahydropyrido(4,3-d)pyrimidines |
| GB0100620D0 (en) * | 2001-01-10 | 2001-02-21 | Vernalis Res Ltd | Chemical cokpounds V |
| DE602004014347D1 (de) * | 2003-03-12 | 2008-07-24 | Millennium Pharm Inc | Chinazolin-derivate als tgf-beta-inhibitoren |
| CA2543710A1 (en) * | 2003-11-03 | 2005-05-12 | Warner-Lambert Company Llc | Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| EP1928461B1 (en) | 2005-08-04 | 2012-01-04 | Janssen Pharmaceutica NV | Pyrimidine compounds as serotonin receptor modulators |
| US7851468B2 (en) * | 2006-05-15 | 2010-12-14 | Cephalon, Inc. | Substituted pyrazolo[3,4-d]pyrimidines |
| EP2209785A1 (en) * | 2007-10-05 | 2010-07-28 | S*BIO Pte Ltd | 2-morpholinylpurines as inhibitors of pi3k |
| WO2010053825A1 (en) | 2008-10-29 | 2010-05-14 | Janssen Pharmaceutica Nv | 2-aminopyrimidine compounds as serotonin receptor modulators |
| KR20110098908A (ko) * | 2008-11-11 | 2011-09-02 | 엑스커버리 홀딩 컴퍼니 엘엘씨 | ＰＩ3Ｋ/ｍＴＯＲ 키나제 억제제 |
| TWI625121B (zh) | 2009-07-13 | 2018-06-01 | 基利科學股份有限公司 | 調節細胞凋亡信號之激酶的抑制劑 |
| US8822447B2 (en) | 2010-04-22 | 2014-09-02 | Janssen Pharmaceutica Nv | Indazole compounds useful as ketohexokinase inhibitors |
| EP2545964A1 (en) | 2011-07-13 | 2013-01-16 | Phenex Pharmaceuticals AG | Novel FXR (NR1H4) binding and activity modulating compounds |
| MX370976B (es) | 2011-11-11 | 2020-01-10 | Gilead Apollo Llc | Inhibidores de acetil coa carboxilasa (acc) y usos de los mismos. |
| UY34573A (es) | 2012-01-27 | 2013-06-28 | Gilead Sciences Inc | Inhibidor de la quinasa que regula la señal de la apoptosis |
| CN103467482B (zh) * | 2012-04-10 | 2017-05-10 | 上海璎黎药业有限公司 | 稠合嘧啶类化合物，其制备方法，中间体，组合物和应用 |
| US10238636B2 (en) | 2014-09-24 | 2019-03-26 | Gilead Sciences, Inc. | Methods of treating liver disease |
| US9586933B2 (en) | 2014-12-23 | 2017-03-07 | Gilead Sciences, Inc. | Processes for preparing ASK1 inhibitors |
| MA41252A (fr) | 2014-12-23 | 2017-10-31 | Gilead Sciences Inc | Formes solides d'un inhibiteur d'ask 1 |
| MX2017008844A (es) | 2015-01-09 | 2018-03-14 | Gilead Apollo Llc | Terapia de combinacion con inhibidor de acetil-coa carboxilasa (acc) para el tratamiento de enfermedad de higado graso no alcoholico. |
| US20190137505A1 (en) * | 2015-08-10 | 2019-05-09 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Biomarkers of methylglyoxal and related methods thereof |
| TN2018000198A1 (en) | 2015-12-29 | 2019-10-04 | Pfizer | Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors |
| CA3155220C (en) | 2016-03-02 | 2024-01-16 | Gilead Apollo, Llc | Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof |
| CA3137479A1 (en) | 2017-03-03 | 2018-09-07 | Gilead Sciences, Inc. | Processes for preparing acc inhibitors and solid forms thereof |
| CA3056890A1 (en) | 2017-03-17 | 2018-09-20 | Regents Of The University Of Colorado, A Body Corporate | Indazole inhibitors of fructokinase (khk) and methods of use in treating khk-mediated disorders or diseases |
| US20180311244A1 (en) | 2017-03-28 | 2018-11-01 | Gilead Sciences, Inc. | Methods of treating liver disease |
| ES2982801T3 (es) | 2017-03-28 | 2024-10-17 | Gilead Sciences Inc | Combinaciones terapéuticas para el tratamiento de las enfermedades hepáticas |
| EP3609496A1 (en) | 2017-04-12 | 2020-02-19 | Gilead Sciences, Inc. | Methods of treating liver disease |
| CN111182904A (zh) | 2017-10-06 | 2020-05-19 | 吉利德科学公司 | 包含acc抑制剂的组合治疗 |
| US12161621B2 (en) | 2018-07-16 | 2024-12-10 | The Regents Of The University Of Colorado | Methods for fructokinase mediation of alcohol craving and alcohol induced liver disease |
| TWI714231B (zh) | 2018-09-04 | 2020-12-21 | 美商美國禮來大藥廠 | 2,6-二胺基吡啶化合物 |
| KR102558308B1 (ko) | 2018-09-27 | 2023-07-24 | 주식회사 엘지화학 | 3-아자바이사이클로[3,1,1]헵탄 유도체 및 이를 포함하는 약제학적 조성물 |
| WO2020156445A1 (zh) * | 2019-01-29 | 2020-08-06 | 山东轩竹医药科技有限公司 | 己酮糖激酶抑制剂及其用途 |
| WO2020172075A1 (en) | 2019-02-19 | 2020-08-27 | Gilead Sciences, Inc. | Solid forms of fxr agonists |
| US20220143153A1 (en) | 2019-03-08 | 2022-05-12 | The Regents Of The University Of California | Compositions and methods for treating acne |
| MX2021012679A (es) | 2019-04-17 | 2021-11-12 | Colorado Res Partners Llc | Nuevos compuestos y metodos de uso para el tratamiento de enfermedades o trastornos relacionados con la fructosa. |
| CN111978296A (zh) | 2019-05-22 | 2020-11-24 | 山东轩竹医药科技有限公司 | 己酮糖激酶抑制剂及其用途 |
| TWI750685B (zh) | 2019-06-17 | 2021-12-21 | 美商美國禮來大藥廠 | 二取代吡唑化合物 |
| WO2021129737A1 (zh) | 2019-12-24 | 2021-07-01 | 南京明德新药研发有限公司 | 具有khk抑制作用的化合物 |
| WO2021129817A1 (zh) | 2019-12-25 | 2021-07-01 | 南京明德新药研发有限公司 | 具有果糖激酶(khk)抑制作用的嘧啶类化合物 |
| US12479829B2 (en) | 2020-02-13 | 2025-11-25 | Eli Lilly And Company | 2-[2-methylazetidin-1-yl]-4-phenyl-6-(trifluoromethyl)-pyrimidine compounds |
| CN111423420A (zh) | 2020-04-30 | 2020-07-17 | 广州博济医药生物技术股份有限公司 | 作为己酮糖激酶抑制剂的并环化合物 |
| CN114181198B (zh) | 2020-09-15 | 2025-07-15 | 山东轩竹医药科技有限公司 | 嘧啶衍生物类己酮糖激酶抑制剂及其用途 |
| EP4269404A4 (en) * | 2020-12-25 | 2024-12-04 | Xizang Haisco Pharmaceutical Co., Ltd. | KETOHEXOKINASE INHIBITORS AND USE THEREOF |
| CN114805312A (zh) | 2021-01-29 | 2022-07-29 | 上海拓界生物医药科技有限公司 | 一种己酮糖激酶抑制剂及其制备方法 |
| CN114989143A (zh) | 2021-03-02 | 2022-09-02 | 山东轩竹医药科技有限公司 | 并环类己酮糖激酶抑制剂及其用途 |
| WO2022211595A1 (ko) | 2021-04-01 | 2022-10-06 | 주식회사 엘지화학 | 옥사디아졸 화합물 및 이를 포함하는 약제학적 조성물 |
-
2022
- 2022-03-25 ES ES22719399T patent/ES3061522T3/es active Active
- 2022-03-25 PL PL22719399.2T patent/PL4313967T3/pl unknown
- 2022-03-25 US US17/704,440 patent/US12410160B2/en active Active
- 2022-03-25 EP EP25206447.2A patent/EP4681774A3/en active Pending
- 2022-03-25 EP EP22719399.2A patent/EP4313967B1/en active Active
- 2022-03-25 JP JP2023560087A patent/JP7705475B2/ja active Active
- 2022-03-25 CN CN202280024429.7A patent/CN117120429A/zh active Pending
- 2022-03-25 KR KR1020237035032A patent/KR20230158542A/ko active Pending
- 2022-03-25 AU AU2022252182A patent/AU2022252182B2/en active Active
- 2022-03-25 CA CA3214961A patent/CA3214961A1/en active Pending
- 2022-03-25 WO PCT/US2022/021912 patent/WO2022212194A1/en not_active Ceased
- 2022-03-28 TW TW113132589A patent/TW202448875A/zh unknown
- 2022-03-28 TW TW111111557A patent/TWI855308B/zh active
- 2022-03-29 AR ARP220100751A patent/AR125238A1/es not_active Application Discontinuation
-
2024
- 2024-12-04 JP JP2024211090A patent/JP7778900B2/ja active Active
-
2025
- 2025-05-19 AU AU2025203602A patent/AU2025203602A1/en active Pending
- 2025-08-22 US US19/307,911 patent/US20260092053A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023538408A5 (cg-RX-API-DMAC10.html) | ||
| WO2022031994A1 (en) | Glp-1r agonists and uses thereof | |
| JP2024517847A5 (cg-RX-API-DMAC10.html) | ||
| KR100633844B1 (ko) | 2-시아노-4-플루오로피롤리딘 유도체 또는 그의 염 | |
| Duncia et al. | The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist | |
| JP2024505250A5 (cg-RX-API-DMAC10.html) | ||
| AU737735B2 (en) | Lymphocyte function antigen-1 antagonists | |
| US8778881B2 (en) | Peptidic vasopressin receptor agonists | |
| RU2006132463A (ru) | Антагонисты рецептора хемокина | |
| JP2015524476A5 (cg-RX-API-DMAC10.html) | ||
| KR20240150488A (ko) | Glp-1r 작용제로서의 화합물 | |
| TW201024268A (en) | Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use | |
| WO2010129843A1 (en) | Dihydronaphthyridinyl and related compounds for use in treating ophthalmological disorders | |
| CN101965339A (zh) | 新的儿茶酚衍生物、含有其的药物组合物、儿茶酚衍生物的应用以及药物组合物的应用 | |
| CZ20022352A3 (cs) | 4-pyridinyl-N-acyl-L-fenylalaniny | |
| JP2011526917A5 (cg-RX-API-DMAC10.html) | ||
| JP2013523642A (ja) | グルカゴン受容体拮抗薬としての新規なスピロイミダゾロン誘導体、組成物およびそれらの使用方法 | |
| CZ20022305A3 (cs) | Kondenzované azepiny jako vazopresinoví agonisté | |
| EP3939989A1 (en) | Cyclic peptides multimers targeting alpha 4beta 7 integrin | |
| JP2022529466A (ja) | 二環式及び三環式化合物 | |
| JP2024041835A (ja) | 置換テトラヒドロシクロペンタ［ｃ］ピロール、置換ジヒドロピロリジン、その類似体、およびそれらを使用する方法 | |
| EP2192116A1 (en) | Indazole acrylic acid amide compound | |
| US5434167A (en) | Imidazolines N-substituted by a biphenylmethyl group, their medical use and the pharmaceutical compositions therefor | |
| AU2001283045A1 (en) | Lactam inhibitors of factor XA which are useful for the treatment of thrombosis | |
| CZ20012984A3 (cs) | Phenylalaninolové deriváty |